The National Academies of Sciences, Engineering and Medicine
HUMAN GENE-EDITING INITIATIVE

International Summit on Human Gene Editing

Statement of Task and Planning Committee

The National Academy of Sciences, National Academy of Medicine, Chinese Academy of Sciences, and the Royal Society of the UK will organize an International Summit in Washington, D.C., in December 2015 on recent scientific developments in human gene editing and the range of ethical and governance issues associated with these advances.

The meeting will consider issues such as the current state of the science and available technologies; the rationale(s) for and potential benefits and risks inherent in conducting such research and in potential applications; existing (as well as potentially needed) regulatory principles, standards, or guidance for such research and potential applications; ethical concerns; legal considerations; and ways to engage critical stakeholders. An ad hoc committee will organize the meeting as well as commission papers to inform the discussions. The meeting will consist of invited presentations and discussions and will include participation from experts from countries with significant research underway or being launched on human gene editing.

The members of the committee planning the international summit are:

David Baltimore (chair), president emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology, Pasadena
United States

Françoise Baylis, professor and Canada Research Chair in Bioethics and Philosophy, Dalhousie University, Nova Scotia
Canada

Paul Berg, Robert W. and Vivian K. Cahill Professor Emeritus and director emeritus, Beckman Center for Molecular and Genetic Medicine, Stanford University School of Medicine, Stanford, Calif.
United States

George Q. Daley, Samuel E. Lux IV Professor of Hematology and Oncology, and director, Stem Cell Transplantation Program, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston
United States

Jennifer A. Doudna, investigator, Howard Hughes Medical Institute; and professor, department of molecular and cell biology, Lawrence Berkeley National Laboratory, and department of chemistry, University of California, Berkeley
United States

Eric S. Lander, president and director, The Broad Institute of Harvard and MIT, Cambridge, Mass.
United States

Robin Lovell-Badge, group leader and head, division of stem cell biology and developmental genetics, The Francis Crick Institute, London
United Kingdom

Pilar Ossorio, professor of law and bioethics, University of Wisconsin; and ethics scholar, Morgridge Institute for Research, Madison
United States

Duanqing Pei, professor and director general, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou
China

Adrian Thrasher, professor of paediatric immunology, University College London
United Kingdom

Ernst-Ludwig Winnacker, professor emeritus and director emeritus, Gene Center, Ludwig-Maximilians University, Munich
Germany

Qi Zhou, professor and deputy director, Institute of Zoology, Chinese Academy of Sciences, Beijing
China